PMID- 33299497 OWN - NLM STAT- MEDLINE DCOM- 20210819 LR - 20220418 IS - 1875-8630 (Electronic) IS - 0278-0240 (Print) IS - 0278-0240 (Linking) VI - 2020 DP - 2020 TI - Serum TNF-alpha Level Is Associated with Disease Severity in Adult Patients with Immunoglobulin A Vasculitis Nephritis. PG - 5514145 LID - 10.1155/2020/5514145 [doi] LID - 5514145 AB - BACKGROUND: Tumor necrosis factor-alpha (TNF-alpha) is a proinflammatory factor involved in the pathogenesis of immunoglobulin A vasculitis (IgAV). The association between serum TNF-alpha and disease severity in adult patients with IgAV nephritis (IgAV-N) has been inadequately evaluated. METHODS: Serum TNF-alpha was measured by chemiluminescence immunoassay in 53 renal biopsy-proved IgAV-N patients, 53 healthy controls, and 53 IgA nephropathy (IgAN) patients. The correlations of clinicopathologic parameters of IgAV-N patients with serum TNF-alpha were analyzed. RESULTS: In this cross-sectional study, the median age of IgAV-N patients was 29 (25-37) years, and 67.9% were female. Serum TNF-alpha was significantly higher in the IgAV-N group than in the healthy group [7.4 (5.7-9.4) pg/mL vs. 5.9 (5.0, 7.1) pg/mL, P = 0.001], but comparable with sex, age, and estimated glomerular filtration rate (eGFR) grade-matched IgAN patients. Serum creatinine (P = 0.006) and serum cystatin C (P = 0.001) were positively correlated with serum TNF-alpha level, while albumin (P = 0.014) and eGFR (P = 0.021) were negatively correlated with serum TNF-alpha level. Multivariate linear regression analysis revealed that eGFR (P = 0.007) was an independent clinical predictor of serum TNF-alpha. Patients with higher pathological classification grade also had higher serum TNF-alpha. CONCLUSIONS: Serum TNF-alpha is associated with renal function and the pathological classification of adult patients with IgAV-N. TNF-alpha is a potential biomarker for the assessment of IgAV-N severity. CI - Copyright (c) 2020 Haiting Wu et al. FAU - Wu, Haiting AU - Wu H AUID- ORCID: 0000-0001-5725-021X AD - Division of Nephrology, Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China. FAU - Wen, Yubing AU - Wen Y AUID- ORCID: 0000-0003-0438-8447 AD - Division of Nephrology, Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China. FAU - Yue, Cai AU - Yue C AUID- ORCID: 0000-0001-5754-0225 AD - Division of Nephrology, Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China. FAU - Li, Xuemei AU - Li X AUID- ORCID: 0000-0002-5966-6240 AD - Division of Nephrology, Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China. FAU - Gao, Ruitong AU - Gao R AUID- ORCID: 0000-0002-2117-5032 AD - Division of Nephrology, Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China. LA - eng PT - Journal Article DEP - 20201125 PL - United States TA - Dis Markers JT - Disease markers JID - 8604127 RN - 0 (Biomarkers) RN - 0 (CST3 protein, human) RN - 0 (Cystatin C) RN - 0 (TNF protein, human) RN - 0 (Tumor Necrosis Factor-alpha) RN - AYI8EX34EU (Creatinine) SB - IM MH - Adult MH - Biomarkers/*blood MH - Case-Control Studies MH - Creatinine/blood MH - Cross-Sectional Studies MH - Cystatin C/blood MH - Female MH - Glomerular Filtration Rate MH - Glomerulonephritis, IGA/blood/metabolism/*physiopathology MH - Humans MH - Linear Models MH - Luminescent Measurements MH - Male MH - Severity of Illness Index MH - Tumor Necrosis Factor-alpha/*blood MH - *Up-Regulation MH - Vasculitis/blood/metabolism/*physiopathology MH - Young Adult PMC - PMC7710402 COIS- The authors declare no conflict of interest related to this study. EDAT- 2020/12/11 06:00 MHDA- 2021/08/20 06:00 PMCR- 2020/11/25 CRDT- 2020/12/10 05:57 PHST- 2020/02/22 00:00 [received] PHST- 2020/11/08 00:00 [revised] PHST- 2020/11/17 00:00 [accepted] PHST- 2020/12/10 05:57 [entrez] PHST- 2020/12/11 06:00 [pubmed] PHST- 2021/08/20 06:00 [medline] PHST- 2020/11/25 00:00 [pmc-release] AID - 10.1155/2020/5514145 [doi] PST - epublish SO - Dis Markers. 2020 Nov 25;2020:5514145. doi: 10.1155/2020/5514145. eCollection 2020.